Management of Heparin Therapy During Coronary Intervention for Severe RCA Stenosis
Heparin Administration Protocol for Coronary Intervention
- Patients with severe Right Coronary Artery (RCA) stenosis should receive intravenous heparin during intervention with an initial bolus of 70-100 U/kg to maintain an activated clotting time (ACT) between 250-350 seconds, as recommended by the American College of Cardiology and American Heart Association 1, 2
- For patients undergoing percutaneous coronary intervention (PCI) without glycoprotein IIb/IIIa inhibitors, administer weight-adjusted heparin at 100 U/kg as an initial bolus to achieve an ACT of 250-300 seconds with the HemoTec device or 300-350 seconds with the Hemochron device, according to the American College of Cardiology 3
- When glycoprotein IIb/IIIa inhibitors are used concurrently, reduce the heparin dose to 70 U/kg to target an ACT of approximately 200 seconds, as suggested by the American Heart Association 1
Rationale for Heparin Use During Coronary Intervention
- Intra-arterial clot formation is a major concern during coronary interventions and can have disastrous consequences if not properly managed, highlighting the importance of anticoagulation therapy during these procedures, as noted by the Journal of Neurointerventional Surgery 2
- Deep arterial injury associated with balloon angioplasty and stent thrombogenicity creates a highly thrombogenic surface, with intramural thrombosis observed in >90% of deeply injured arteries even with anticoagulation, according to the European Society of Cardiology 3
- The lack of randomized clinical trials comparing heparin versus placebo during PCI reflects the strong consensus that anticoagulation therapy is a requirement during these procedures, as stated by the European Heart Journal 4
Post-Procedure Anticoagulation Management
- After uncomplicated coronary intervention, routine post-procedural intravenous heparin administration is generally not recommended due to lack of evidence of definite benefits and potential for increased bleeding complications, as recommended by the American College of Chest Physicians 3
- For patients with angiographically visible dissections, mural thrombosis, or progressive/new symptoms, continue heparin to maintain APTT of 1.5-2.3 times control values for 24 hours, according to the American Heart Association 3
Special Considerations
- For patients receiving chronic warfarin treatment, cessation of warfarin is recommended 4 days before the procedure, with postoperative intravenous heparin considered only for patients with recent arterial or venous thromboembolisms, as suggested by the American College of Cardiology 3
- For patients with high thrombotic risk, such as those with recent thrombotic events or severe coronary disease, maintaining adequate anticoagulation is particularly important, as noted by the American College of Chest Physicians 5